SG Americas Securities’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

SG Americas Securities’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,047	Closed	-$83K	–	3685
2018 Q4	$83K	Buy	+6,047	New	+$106K	﹤0.01%	2760
2017 Q1	–	Sell	-1,209	Closed	-$112K	–	3611
2016 Q4	$112K	Buy	+1,209	New	+$136K	﹤0.01%	2795
2015 Q4	–	Sell	-538	Closed	-$174K	–	3035
2015 Q3	$174K	Sell	538 -243	-31%	-$107K	﹤0.01%	1537
2015 Q2	$311K	Buy	781 +574	+277%	+$244K	﹤0.01%	1755
2015 Q1	$102K	Sell	207 -405	-66%	-$157K	﹤0.01%	2277
2014 Q4	$219K	Buy	+612	New	+$182K	﹤0.01%	2353

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

SG Americas Securities's LUMO Position: Q1 2019 in Review

SG Americas Securities sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2019, closing a stake of 6,047 shares — an estimated $83K sold.

SG Americas Securities first reported a position in LUMO in Q4 2014 and held it in 6 quarters. The position peaked at $311K in Q2 2015. 82 funds tracked by Wall St. Rank hold LUMO as of Q1 2019.

SG Americas Securities reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
SG Americas Securities sold 6,047 Lumos Pharma, Inc. Common Stock shares in Q1 2019, an estimated $83K.
SG Americas Securities first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 6 quarters.
SG Americas Securities's Lumos Pharma, Inc. Common Stock position peaked at $311K in Q2 2015.
82 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2019.

Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.